CN103191038B - Toothpaste for assisting gingivitis treatment - Google Patents
Toothpaste for assisting gingivitis treatment Download PDFInfo
- Publication number
- CN103191038B CN103191038B CN201310113804.8A CN201310113804A CN103191038B CN 103191038 B CN103191038 B CN 103191038B CN 201310113804 A CN201310113804 A CN 201310113804A CN 103191038 B CN103191038 B CN 103191038B
- Authority
- CN
- China
- Prior art keywords
- weight portions
- radix
- stir
- wine
- rhizoma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 208000007565 gingivitis Diseases 0.000 title claims abstract description 32
- 229940034610 toothpaste Drugs 0.000 title abstract description 16
- 239000000606 toothpaste Substances 0.000 title abstract description 16
- 239000003814 drug Substances 0.000 claims abstract description 50
- 239000000203 mixture Substances 0.000 claims abstract description 33
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 13
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 48
- 238000001816 cooling Methods 0.000 claims description 25
- 239000000706 filtrate Substances 0.000 claims description 24
- 239000000843 powder Substances 0.000 claims description 24
- 241000628997 Flos Species 0.000 claims description 18
- 210000000582 semen Anatomy 0.000 claims description 18
- 238000003756 stirring Methods 0.000 claims description 18
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 claims description 17
- 239000007788 liquid Substances 0.000 claims description 17
- UAJTZZNRJCKXJN-UHFFFAOYSA-M sodium;2-dodecoxy-2-oxoethanesulfonate Chemical compound [Na+].CCCCCCCCCCCCOC(=O)CS([O-])(=O)=O UAJTZZNRJCKXJN-UHFFFAOYSA-M 0.000 claims description 17
- 241001521474 Liriope <hydrozoan> Species 0.000 claims description 16
- 241001057584 Myrrha Species 0.000 claims description 16
- 230000001476 alcoholic effect Effects 0.000 claims description 12
- 238000010992 reflux Methods 0.000 claims description 12
- 229940079593 drug Drugs 0.000 claims description 10
- 230000002829 reductive effect Effects 0.000 claims description 7
- 240000009235 Rubia cordifolia Species 0.000 claims description 6
- 239000003610 charcoal Substances 0.000 claims description 6
- 238000001914 filtration Methods 0.000 claims description 6
- 238000002360 preparation method Methods 0.000 claims description 6
- 230000000694 effects Effects 0.000 abstract description 33
- 239000011230 binding agent Substances 0.000 abstract description 3
- 239000003795 chemical substances by application Substances 0.000 abstract description 3
- 239000003381 stabilizer Substances 0.000 abstract description 3
- 239000004094 surface-active agent Substances 0.000 abstract description 3
- 239000003242 anti bacterial agent Substances 0.000 abstract 1
- 235000003599 food sweetener Nutrition 0.000 abstract 1
- 239000003906 humectant Substances 0.000 abstract 1
- 239000003765 sweetening agent Substances 0.000 abstract 1
- 239000008280 blood Substances 0.000 description 54
- 210000004369 blood Anatomy 0.000 description 54
- 210000000214 mouth Anatomy 0.000 description 31
- 210000002784 stomach Anatomy 0.000 description 24
- 208000002193 Pain Diseases 0.000 description 17
- 210000004185 liver Anatomy 0.000 description 16
- 230000008961 swelling Effects 0.000 description 16
- 230000036407 pain Effects 0.000 description 15
- 230000001717 pathogenic effect Effects 0.000 description 15
- 230000001737 promoting effect Effects 0.000 description 15
- 210000004072 lung Anatomy 0.000 description 14
- 210000003734 kidney Anatomy 0.000 description 13
- 231100000614 poison Toxicity 0.000 description 11
- 206010007247 Carbuncle Diseases 0.000 description 10
- 230000017531 blood circulation Effects 0.000 description 10
- 210000000952 spleen Anatomy 0.000 description 10
- 206010011224 Cough Diseases 0.000 description 9
- 208000001848 dysentery Diseases 0.000 description 9
- 239000003440 toxic substance Substances 0.000 description 9
- 208000032843 Hemorrhage Diseases 0.000 description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
- 210000002429 large intestine Anatomy 0.000 description 8
- 230000001047 pyretic effect Effects 0.000 description 8
- 208000006820 Arthralgia Diseases 0.000 description 7
- 206010018276 Gingival bleeding Diseases 0.000 description 7
- 235000009508 confectionery Nutrition 0.000 description 7
- 201000010099 disease Diseases 0.000 description 7
- 210000004195 gingiva Anatomy 0.000 description 7
- 208000014674 injury Diseases 0.000 description 7
- 231100000419 toxicity Toxicity 0.000 description 7
- 230000001988 toxicity Effects 0.000 description 7
- 201000000736 Amenorrhea Diseases 0.000 description 6
- 206010001928 Amenorrhoea Diseases 0.000 description 6
- 201000004624 Dermatitis Diseases 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 206010061218 Inflammation Diseases 0.000 description 6
- 206010030113 Oedema Diseases 0.000 description 6
- 208000027418 Wounds and injury Diseases 0.000 description 6
- 231100000540 amenorrhea Toxicity 0.000 description 6
- 208000010668 atopic eczema Diseases 0.000 description 6
- 210000001124 body fluid Anatomy 0.000 description 6
- 239000010839 body fluid Substances 0.000 description 6
- 208000001780 epistaxis Diseases 0.000 description 6
- 230000023597 hemostasis Effects 0.000 description 6
- 208000004371 toothache Diseases 0.000 description 6
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 5
- 230000000844 anti-bacterial effect Effects 0.000 description 5
- 230000001580 bacterial effect Effects 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 235000013305 food Nutrition 0.000 description 5
- 230000001939 inductive effect Effects 0.000 description 5
- 230000004054 inflammatory process Effects 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 230000035922 thirst Effects 0.000 description 5
- 230000008736 traumatic injury Effects 0.000 description 5
- 206010000087 Abdominal pain upper Diseases 0.000 description 4
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 4
- 208000015220 Febrile disease Diseases 0.000 description 4
- 208000024283 Gingival haemorrhages Diseases 0.000 description 4
- 208000034507 Haematemesis Diseases 0.000 description 4
- 206010019233 Headaches Diseases 0.000 description 4
- 206010023126 Jaundice Diseases 0.000 description 4
- 241000699670 Mus sp. Species 0.000 description 4
- 240000005373 Panax quinquefolius Species 0.000 description 4
- 235000003140 Panax quinquefolius Nutrition 0.000 description 4
- 208000025747 Rheumatic disease Diseases 0.000 description 4
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 4
- 238000009825 accumulation Methods 0.000 description 4
- 208000002399 aphthous stomatitis Diseases 0.000 description 4
- 210000001367 artery Anatomy 0.000 description 4
- 230000000740 bleeding effect Effects 0.000 description 4
- 230000004087 circulation Effects 0.000 description 4
- 239000000084 colloidal system Substances 0.000 description 4
- 230000007812 deficiency Effects 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 231100000869 headache Toxicity 0.000 description 4
- 210000002216 heart Anatomy 0.000 description 4
- 208000006750 hematuria Diseases 0.000 description 4
- 208000013403 hyperactivity Diseases 0.000 description 4
- 210000000936 intestine Anatomy 0.000 description 4
- 230000002147 killing effect Effects 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 201000001245 periodontitis Diseases 0.000 description 4
- 230000000552 rheumatic effect Effects 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- 208000011580 syndromic disease Diseases 0.000 description 4
- 210000003462 vein Anatomy 0.000 description 4
- 206010010726 Conjunctival oedema Diseases 0.000 description 3
- 206010010774 Constipation Diseases 0.000 description 3
- 208000005171 Dysmenorrhea Diseases 0.000 description 3
- 206010013935 Dysmenorrhoea Diseases 0.000 description 3
- 208000025157 Oral disease Diseases 0.000 description 3
- 208000004880 Polyuria Diseases 0.000 description 3
- 206010037660 Pyrexia Diseases 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- 208000033809 Suppuration Diseases 0.000 description 3
- 206010053615 Thermal burn Diseases 0.000 description 3
- 206010047700 Vomiting Diseases 0.000 description 3
- 210000001015 abdomen Anatomy 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 230000029087 digestion Effects 0.000 description 3
- 230000035619 diuresis Effects 0.000 description 3
- 208000002173 dizziness Diseases 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 208000035861 hematochezia Diseases 0.000 description 3
- 210000003026 hypopharynx Anatomy 0.000 description 3
- 210000004283 incisor Anatomy 0.000 description 3
- 208000030194 mouth disease Diseases 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 230000028327 secretion Effects 0.000 description 3
- 206010040872 skin infection Diseases 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 231100000331 toxic Toxicity 0.000 description 3
- 230000002588 toxic effect Effects 0.000 description 3
- 210000001835 viscera Anatomy 0.000 description 3
- 230000008673 vomiting Effects 0.000 description 3
- 206010002091 Anaesthesia Diseases 0.000 description 2
- 206010003011 Appendicitis Diseases 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 206010059866 Drug resistance Diseases 0.000 description 2
- 206010013954 Dysphoria Diseases 0.000 description 2
- 201000000297 Erysipelas Diseases 0.000 description 2
- 206010017553 Furuncle Diseases 0.000 description 2
- 206010052359 Gingival abscess Diseases 0.000 description 2
- 206010018612 Gonorrhoea Diseases 0.000 description 2
- 206010020565 Hyperaemia Diseases 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 206010061245 Internal injury Diseases 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 206010027514 Metrorrhagia Diseases 0.000 description 2
- 206010035664 Pneumonia Diseases 0.000 description 2
- 208000001431 Psychomotor Agitation Diseases 0.000 description 2
- 206010038743 Restlessness Diseases 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 230000037005 anaesthesia Effects 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- 230000002882 anti-plaque Effects 0.000 description 2
- 230000001754 anti-pyretic effect Effects 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 230000023555 blood coagulation Effects 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 230000001680 brushing effect Effects 0.000 description 2
- 229910000019 calcium carbonate Inorganic materials 0.000 description 2
- 235000013877 carbamide Nutrition 0.000 description 2
- 239000004202 carbamide Substances 0.000 description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 210000000038 chest Anatomy 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 201000006549 dyspepsia Diseases 0.000 description 2
- 239000003172 expectorant agent Substances 0.000 description 2
- 230000003419 expectorant effect Effects 0.000 description 2
- 210000000232 gallbladder Anatomy 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 238000003304 gavage Methods 0.000 description 2
- 208000014617 hemorrhoid Diseases 0.000 description 2
- 230000002757 inflammatory effect Effects 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 210000000629 knee joint Anatomy 0.000 description 2
- FYDKNKUEBJQCCN-UHFFFAOYSA-N lanthanum(3+);trinitrate Chemical compound [La+3].[O-][N+]([O-])=O.[O-][N+]([O-])=O.[O-][N+]([O-])=O FYDKNKUEBJQCCN-UHFFFAOYSA-N 0.000 description 2
- 201000004792 malaria Diseases 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 210000004877 mucosa Anatomy 0.000 description 2
- 238000012148 non-surgical treatment Methods 0.000 description 2
- 244000045947 parasite Species 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 230000003239 periodontal effect Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000010791 quenching Methods 0.000 description 2
- 206010037844 rash Diseases 0.000 description 2
- 230000008439 repair process Effects 0.000 description 2
- 210000003296 saliva Anatomy 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 2
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 235000019640 taste Nutrition 0.000 description 2
- 230000017423 tissue regeneration Effects 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- 239000000080 wetting agent Substances 0.000 description 2
- ZAUYNCUCMJDAHW-UHFFFAOYSA-N 1-ethenylpyrrolidin-2-one;hydrogen peroxide;molecular iodine Chemical compound OO.II.C=CN1CCCC1=O ZAUYNCUCMJDAHW-UHFFFAOYSA-N 0.000 description 1
- XJLDYKIEURAVBW-UHFFFAOYSA-N 3-decanone Chemical compound CCCCCCCC(=O)CC XJLDYKIEURAVBW-UHFFFAOYSA-N 0.000 description 1
- XLYLQUQHYUOPIW-UHFFFAOYSA-N 3-oxo-Tetradecanal Chemical compound CCCCCCCCCCCC(=O)CC=O XLYLQUQHYUOPIW-UHFFFAOYSA-N 0.000 description 1
- LVRVABPNVHYXRT-BQWXUCBYSA-N 52906-92-0 Chemical compound C([C@H](N)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(O)=O)C(C)C)C1=CC=CC=C1 LVRVABPNVHYXRT-BQWXUCBYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 208000006400 Arbovirus Encephalitis Diseases 0.000 description 1
- 206010003445 Ascites Diseases 0.000 description 1
- 208000004429 Bacillary Dysentery Diseases 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 208000019838 Blood disease Diseases 0.000 description 1
- 206010006002 Bone pain Diseases 0.000 description 1
- 206010006326 Breath odour Diseases 0.000 description 1
- 206010007882 Cellulitis Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 241001269238 Data Species 0.000 description 1
- QBDCOUHKEVYWLO-UHFFFAOYSA-N Decanoylacetaldehyde Natural products CCCCCCCCCC(=O)CC=O QBDCOUHKEVYWLO-UHFFFAOYSA-N 0.000 description 1
- 208000006558 Dental Calculus Diseases 0.000 description 1
- 208000002064 Dental Plaque Diseases 0.000 description 1
- 208000036649 Dysbacteriosis Diseases 0.000 description 1
- 208000027244 Dysbiosis Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010052369 Encephalitis lethargica Diseases 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 206010063560 Excessive granulation tissue Diseases 0.000 description 1
- 206010017915 Gastroenteritis shigella Diseases 0.000 description 1
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 1
- 208000032139 Halitosis Diseases 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 206010025421 Macule Diseases 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 101800002372 Motilin Proteins 0.000 description 1
- 102000002419 Motilin Human genes 0.000 description 1
- 208000005647 Mumps Diseases 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 206010062575 Muscle contracture Diseases 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 235000019082 Osmanthus Nutrition 0.000 description 1
- 241000333181 Osmanthus Species 0.000 description 1
- 201000010183 Papilledema Diseases 0.000 description 1
- 206010033712 Papilloedema Diseases 0.000 description 1
- QGMRQYFBGABWDR-UHFFFAOYSA-M Pentobarbital sodium Chemical compound [Na+].CCCC(C)C1(CC)C(=O)NC(=O)[N-]C1=O QGMRQYFBGABWDR-UHFFFAOYSA-M 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 208000004680 Rectal Fistula Diseases 0.000 description 1
- 206010057071 Rectal tenesmus Diseases 0.000 description 1
- 206010067171 Regurgitation Diseases 0.000 description 1
- 241000293871 Salmonella enterica subsp. enterica serovar Typhi Species 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 244000061458 Solanum melongena Species 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 241000194019 Streptococcus mutans Species 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 208000003443 Unconsciousness Diseases 0.000 description 1
- 206010046814 Uterine prolapse Diseases 0.000 description 1
- 102000055135 Vasoactive Intestinal Peptide Human genes 0.000 description 1
- 108010003205 Vasoactive Intestinal Peptide Proteins 0.000 description 1
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 206010002156 anal fistula Diseases 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000003385 bacteriostatic effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 208000002894 beriberi Diseases 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 208000034158 bleeding Diseases 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 230000021164 cell adhesion Effects 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 208000006111 contracture Diseases 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 201000001747 discharging ear Diseases 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 208000017574 dry cough Diseases 0.000 description 1
- 230000007140 dysbiosis Effects 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 206010014599 encephalitis Diseases 0.000 description 1
- 230000003511 endothelial effect Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 230000005176 gastrointestinal motility Effects 0.000 description 1
- 210000003731 gingival crevicular fluid Anatomy 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 208000001786 gonorrhea Diseases 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 210000001126 granulation tissue Anatomy 0.000 description 1
- 231100000206 health hazard Toxicity 0.000 description 1
- 230000005802 health problem Effects 0.000 description 1
- 208000014951 hematologic disease Diseases 0.000 description 1
- 208000018706 hematopoietic system disease Diseases 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 230000002439 hemostatic effect Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 210000001624 hip Anatomy 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 208000027866 inflammatory disease Diseases 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- VBUWHHLIZKOSMS-RIWXPGAOSA-N invicorp Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)C(C)C)[C@@H](C)O)[C@@H](C)O)C(C)C)C1=CC=C(O)C=C1 VBUWHHLIZKOSMS-RIWXPGAOSA-N 0.000 description 1
- 230000008338 local blood flow Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000005190 lower gingiva Anatomy 0.000 description 1
- 201000003453 lung abscess Diseases 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 208000010805 mumps infectious disease Diseases 0.000 description 1
- 210000002445 nipple Anatomy 0.000 description 1
- 230000000242 pagocytic effect Effects 0.000 description 1
- 230000003119 painkilling effect Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 229960002275 pentobarbital sodium Drugs 0.000 description 1
- 230000001175 peptic effect Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 206010036596 premature ejaculation Diseases 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 238000007634 remodeling Methods 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 201000005113 shigellosis Diseases 0.000 description 1
- 201000009890 sinusitis Diseases 0.000 description 1
- 230000035943 smell Effects 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 238000012109 statistical procedure Methods 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000007910 systemic administration Methods 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 208000012271 tenesmus Diseases 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 210000005189 upper gingiva Anatomy 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 239000002435 venom Substances 0.000 description 1
- 210000001048 venom Anatomy 0.000 description 1
- 231100000611 venom Toxicity 0.000 description 1
- 201000002498 viral encephalitis Diseases 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Landscapes
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310113804.8A CN103191038B (en) | 2013-04-03 | 2013-04-03 | Toothpaste for assisting gingivitis treatment |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310113804.8A CN103191038B (en) | 2013-04-03 | 2013-04-03 | Toothpaste for assisting gingivitis treatment |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103191038A CN103191038A (en) | 2013-07-10 |
CN103191038B true CN103191038B (en) | 2014-12-03 |
Family
ID=48713977
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310113804.8A Expired - Fee Related CN103191038B (en) | 2013-04-03 | 2013-04-03 | Toothpaste for assisting gingivitis treatment |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103191038B (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104127363B (en) * | 2014-08-08 | 2016-09-28 | 管永昱 | Swollen sterilization adult's toothpaste is removed in a kind of antiinflammatory |
CN106063776A (en) * | 2016-05-31 | 2016-11-02 | 安徽皖斛堂生物科技有限公司 | A kind of Herba Dendrobii toothpaste and preparation method thereof |
CN107362120A (en) * | 2017-07-17 | 2017-11-21 | 何家平 | A kind of compound root of bidentate achyranthes Chinese herbal toothpaste technique |
CN107625698A (en) * | 2017-09-30 | 2018-01-26 | 烟台宇诚企业管理咨询有限公司 | A kind of toothpaste for alleviating sensitivity of tooth and preparation method thereof |
CN113244121B (en) * | 2021-07-01 | 2022-12-23 | 苏州工业园区方津口腔诊所有限公司 | Whitening and antibacterial toothpaste |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103156984B (en) * | 2013-04-03 | 2014-07-16 | 刘冰甜 | Traditional Chinese medicine composition for treating gingivitis and preparation method thereof |
-
2013
- 2013-04-03 CN CN201310113804.8A patent/CN103191038B/en not_active Expired - Fee Related
Non-Patent Citations (1)
Title |
---|
中华人民共和国***.化妆品禁用组分.《化妆品卫生规范》.2007, * |
Also Published As
Publication number | Publication date |
---|---|
CN103191038A (en) | 2013-07-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103989618B (en) | For toothpaste treating gingivitis and preparation method thereof | |
CN103191038B (en) | Toothpaste for assisting gingivitis treatment | |
CN102579312B (en) | Toothpaste for preventing and treating gingivitis and preparation method for toothpaste | |
CN102698122B (en) | Traditional Chinese medicinal composition for treating paradentitis, and preparation method and administration method thereof and toothpaste | |
CN103505656A (en) | Chinese medicine preparation for treating stomatitis | |
CN103156984B (en) | Traditional Chinese medicine composition for treating gingivitis and preparation method thereof | |
CN102579988A (en) | Traditional Chinese medicine for preventing and treating gingivitis, Chinese herbal medicine tooth powder and preparation method | |
CN105535582A (en) | A medicine composition for treating gingivitis | |
CN103768490B (en) | A kind of medicine for the treatment of halitosis and preparation method thereof | |
CN103611128B (en) | A kind of collutory of preventing canker sore | |
CN104524227B (en) | A kind of Chinese medicine preparation and preparation method being used for the treatment of dental caries | |
CN105497615A (en) | Toothpaste for treating gingivitis | |
CN104547714B (en) | Chinese traditional medicine for treating periodontitis and preparation method thereof | |
CN103550454A (en) | Traditional Chinese medicine preparation for treating periodontitis | |
CN104306711A (en) | Traditional Chinese medicine for treating oral ulcer | |
CN103705871B (en) | Be used for the treatment of the Chinese medicine preparation of periodontitis | |
CN101897785A (en) | Pharmaceutical composition with acne-dispelling function and preparation method thereof | |
CN105434952A (en) | Medicine for treating scarlatina and preparation method thereof | |
CN104958581A (en) | Chinese herbal preparation for treating epifolliculitis and preparing method of Chinese herbal preparation for treating epifolliculitis | |
CN103623279B (en) | Medicine for treating infant measles and preparation method of medicine | |
CN103028041B (en) | Traditional Chinese medicine composition for treating acute nasosinusitis of children and preparation method of traditional Chinese medicine composition | |
CN103989902A (en) | Traditional Chinese medicine composition used for treating gingivitis and preparation method thereof | |
CN103893657B (en) | A kind of Traditional Chinese medicine lozenge and preparation method for the treatment of halitosis | |
CN103028040A (en) | Traditional Chinese medicine composition for treating infantile chronic nasosinusitis and preparation method of traditional Chinese medicine composition | |
CN106729083A (en) | It is a kind of to treat medicine of periodontitis and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: QINGDAO HUAREN TECHNOLOGY INCUBATOR CO., LTD. Free format text: FORMER OWNER: LIU BINGTIAN Effective date: 20141028 |
|
C41 | Transfer of patent application or patent right or utility model | ||
C53 | Correction of patent for invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Song Zhenyu Inventor after: Zhang Li Inventor before: Liu Bingtian |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: LIU BINGTIAN TO: SONG ZHENYU ZHANG LI |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20141028 Address after: 266071 Shandong city of Qingdao province Hongkong City Road No. 32 floor 801-A room 8 Applicant after: Qingdao Huaren Technology Incubator Co., Ltd. Address before: Taizhou City, Shandong province Qingdao City Road 266071 No. 5 unit 3, room 402 Applicant before: Liu Bingtian |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C56 | Change in the name or address of the patentee | ||
CP02 | Change in the address of a patent holder |
Address after: 266071 Shandong city of Qingdao province Hongkong City Road No. 32 floor 801-A room 8 Patentee after: Qingdao Huaren Technology Incubator Co., Ltd. Address before: 266071 Qingdao City, Shandong Province Patentee before: Qingdao Huaren Technology Incubator Co., Ltd. |
|
CI01 | Correction of invention patent gazette |
Correction item: Address of the patentee Correct: Shandong City, Qingdao province Hongkong City Road No. 32 8 floor room 801 False: Qingdao, Shandong, China Number: 49 Volume: 30 |
|
CI03 | Correction of invention patent |
Correction item: Address of the patentee Correct: Shandong City, Qingdao province Hongkong City Road No. 32 floor 801-A room 8 False: Qingdao, Shandong, China Number: 49 Page: The title page Volume: 30 |
|
ERR | Gazette correction | ||
RECT | Rectification | ||
TR01 | Transfer of patent right |
Effective date of registration: 20171023 Address after: Lang Jun Center No. 28 road 401120 Chongqing city Yubei District Huanglong longta Street Building 3 2-1 Patentee after: Chongqing AOPO Ruisen Technology Co. Ltd. Address before: 266071 Shandong city of Qingdao province Hongkong City Road No. 32, Minmetals Building 8 801-A room Patentee before: Qingdao Huaren Technology Incubator Co., Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20180529 Address after: 401120 293 Xingcheng Avenue, Hui Xing street, Yubei District, Chongqing, with 7 buildings 9. Patentee after: CHONGQING XUANNU BIOTECHNOLOGY CO., LTD. Address before: 401120, 3, 2-1, Langjun center, 28 Huanglong Road, Dragon Tower Street, Yubei District, Chongqing. Patentee before: Chongqing AOPO Ruisen Technology Co. Ltd. |
|
TR01 | Transfer of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20141203 Termination date: 20190403 |